Logo image of CGTL

CREATIVE GLOBAL TECHNOLOGY-A (CGTL) Stock Fundamental Analysis

NASDAQ:CGTL - Nasdaq - KYG2563P1028 - Common Stock - Currency: USD

0.9229  +0 (+0.4%)

Premarket: 1.3 +0.38 (+40.86%)

Fundamental Rating

6

CGTL gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 125 industry peers in the Electronic Equipment, Instruments & Components industry. While CGTL has a great health rating, its profitability is only average at the moment. CGTL has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

CGTL had positive earnings in the past year.
In the past year CGTL has reported a negative cash flow from operations.
CGTL Yearly Net Income VS EBIT VS OCF VS FCFCGTL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 0 2M -2M 4M

1.2 Ratios

Looking at the Return On Assets, with a value of 35.61%, CGTL belongs to the top of the industry, outperforming 99.20% of the companies in the same industry.
With an excellent Return On Equity value of 43.18%, CGTL belongs to the best of the industry, outperforming 97.60% of the companies in the same industry.
Looking at the Return On Invested Capital, with a value of 43.31%, CGTL belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for CGTL is significantly above the industry average of 9.35%.
The 3 year average ROIC (40.34%) for CGTL is below the current ROIC(43.31%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 35.61%
ROE 43.18%
ROIC 43.31%
ROA(3y)32%
ROA(5y)N/A
ROE(3y)40.9%
ROE(5y)N/A
ROIC(3y)40.34%
ROIC(5y)N/A
CGTL Yearly ROA, ROE, ROICCGTL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 20 40 60 80

1.3 Margins

CGTL has a Profit Margin of 10.35%. This is amongst the best in the industry. CGTL outperforms 85.60% of its industry peers.
In the last couple of years the Profit Margin of CGTL has declined.
CGTL has a better Operating Margin (12.61%) than 83.20% of its industry peers.
In the last couple of years the Operating Margin of CGTL has declined.
CGTL has a Gross Margin of 16.07%. This is in the lower half of the industry: CGTL underperforms 72.00% of its industry peers.
In the last couple of years the Gross Margin of CGTL has declined.
Industry RankSector Rank
OM 12.61%
PM (TTM) 10.35%
GM 16.07%
OM growth 3Y-13.43%
OM growth 5YN/A
PM growth 3Y-15.14%
PM growth 5YN/A
GM growth 3Y-9.23%
GM growth 5YN/A
CGTL Yearly Profit, Operating, Gross MarginsCGTL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 5 10 15 20

10

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CGTL is creating value.
CGTL has less shares outstanding than it did 1 year ago.
CGTL has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CGTL Yearly Shares OutstandingCGTL Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 5M 10M 15M 20M
CGTL Yearly Total Debt VS Total AssetsCGTL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 5M 10M 15M

2.2 Solvency

An Altman-Z score of 11.10 indicates that CGTL is not in any danger for bankruptcy at the moment.
CGTL has a Altman-Z score of 11.10. This is amongst the best in the industry. CGTL outperforms 90.40% of its industry peers.
There is no outstanding debt for CGTL. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 11.1
ROIC/WACC4.68
WACC9.26%
CGTL Yearly LT Debt VS Equity VS FCFCGTL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 0 5M 10M

2.3 Liquidity

A Current Ratio of 5.39 indicates that CGTL has no problem at all paying its short term obligations.
CGTL has a Current ratio of 5.39. This is amongst the best in the industry. CGTL outperforms 82.40% of its industry peers.
A Quick Ratio of 4.04 indicates that CGTL has no problem at all paying its short term obligations.
CGTL has a better Quick ratio (4.04) than 80.80% of its industry peers.
Industry RankSector Rank
Current Ratio 5.39
Quick Ratio 4.04
CGTL Yearly Current Assets VS Current LiabilitesCGTL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 5M 10M 15M

4

3. Growth

3.1 Past

CGTL shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.71%, which is quite good.
Measured over the past years, CGTL shows a very strong growth in Earnings Per Share. The EPS has been growing by 22.21% on average per year.
CGTL shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -28.15%.
Measured over the past years, CGTL shows a very strong growth in Revenue. The Revenue has been growing by 41.14% on average per year.
EPS 1Y (TTM)19.71%
EPS 3Y22.21%
EPS 5YN/A
EPS Q2Q%44.18%
Revenue 1Y (TTM)-28.15%
Revenue growth 3Y41.14%
Revenue growth 5YN/A
Sales Q2Q%-29.17%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CGTL Yearly Revenue VS EstimatesCGTL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 10M 20M 30M 40M 50M

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 3.18, which indicates a rather cheap valuation of CGTL.
CGTL's Price/Earnings ratio is rather cheap when compared to the industry. CGTL is cheaper than 99.20% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.55, CGTL is valued rather cheaply.
Industry RankSector Rank
PE 3.18
Fwd PE N/A
CGTL Price Earnings VS Forward Price EarningsCGTL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CGTL indicates a rather cheap valuation: CGTL is cheaper than 97.60% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 2.7
CGTL Per share dataCGTL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1 1.5 2 2.5

4.3 Compensation for Growth

The decent profitability rating of CGTL may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for CGTL!.
Industry RankSector Rank
Dividend Yield N/A

CREATIVE GLOBAL TECHNOLOGY-A

NASDAQ:CGTL (6/11/2025, 8:00:01 PM)

Premarket: 1.3 +0.38 (+40.86%)

0.9229

+0 (+0.4%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners0.56%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap19.79M
AnalystsN/A
Price TargetN/A
Short Float %N/A
Short Ratio0.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.18
Fwd PE N/A
P/S 0.35
P/FCF N/A
P/OCF N/A
P/B 1.47
P/tB 1.47
EV/EBITDA 2.7
EPS(TTM)0.29
EY31.42%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.17
FCFYN/A
OCF(TTM)-0.16
OCFYN/A
SpS2.62
BVpS0.63
TBVpS0.63
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 35.61%
ROE 43.18%
ROCE 52.54%
ROIC 43.31%
ROICexc 44.78%
ROICexgc 44.78%
OM 12.61%
PM (TTM) 10.35%
GM 16.07%
FCFM N/A
ROA(3y)32%
ROA(5y)N/A
ROE(3y)40.9%
ROE(5y)N/A
ROIC(3y)40.34%
ROIC(5y)N/A
ROICexc(3y)54.15%
ROICexc(5y)N/A
ROICexgc(3y)54.15%
ROICexgc(5y)N/A
ROCE(3y)48.94%
ROCE(5y)N/A
ROICexcg growth 3Y-31.1%
ROICexcg growth 5YN/A
ROICexc growth 3Y-31.1%
ROICexc growth 5YN/A
OM growth 3Y-13.43%
OM growth 5YN/A
PM growth 3Y-15.14%
PM growth 5YN/A
GM growth 3Y-9.23%
GM growth 5YN/A
F-Score4
Asset Turnover3.44
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA 0
Cap/Depr 22.66%
Cap/Sales 0.03%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.39
Quick Ratio 4.04
Altman-Z 11.1
F-Score4
WACC9.26%
ROIC/WACC4.68
Cap/Depr(3y)164.93%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.04%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y22.21%
EPS 5YN/A
EPS Q2Q%44.18%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-28.15%
Revenue growth 3Y41.14%
Revenue growth 5YN/A
Sales Q2Q%-29.17%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y16.76%
EBIT growth 3Y22.19%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-172.73%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-172.3%
OCF growth 3YN/A
OCF growth 5YN/A